Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Money doesn't mean happiness

Money doesn't mean happiness

Company Business Cash Notes
PDL (NASDAQ:PDLI) Cardiovascular, cancer, autoimmune $409.5 8/20/07 - Says it is continuing its corporate strategic review with Merrill

Read the full 276 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE